Comparison by Transoesophageal Assessement of Systolic Right Ventricle Function Measures in Perioperative Care of Pulmonary Transplant.

NCT ID: NCT02887560

Last Updated: 2019-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-05

Study Completion Date

2018-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to describe the early adaptation of the right ventricle assessed by echocardiography to change of pulmonary circulation secondary to pulmonary transplantation.

Secondary objectives include change of haemodynamics measured by transpulmonary thermodilution and evolution of right heart function in terms of primary graft dysfunction grading.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Lung Graft Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All patient

Only one arm has been specified for the protocol. This arm included all study patient (33) for which the intervention is to be administered

Group Type EXPERIMENTAL

transoesophageal echocardiography

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transoesophageal echocardiography

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (over 18 years)
* Patient affiliated to a social protection scheme insurance
* Patient was informed of the study and w gave their consent
* Patient on the lung transplant list
* Patient eligible for a pulmonary transplantation after decision of a multidisciplinary team
* Patients with chronic lung disease with parenchymal dysfunctions (Chronic obstructive pulmonary disease or COPD, alpha-1 antitrypsin deficiency, cystic fibrosis, pulmonary fibrosis, bronchiolitis obliterans organizing pneumonia or BOOP)

Exclusion Criteria

* Minor patients
* Patient under judicial protection, under guardianship
* Patient in exclusion period (determined by a previous study or in progress)
* Patient participating in parallel in another clinical trial that may interfere with the results of the study
* Inability to give informed patient information (emergency, understanding difficulties, etc ...)
* The refusal of patient consent
* The use of cardiopulmonary bypass during lung transplantation
* Uni-pulmonary transplant
* A transplant for idiopathic or primary pulmonary hypertension
* The presence of a cons-indication for transesophageal echocardiography:

o Absolute contraindications:
* Abnormalities of the esophagus: stenosis, tumor, diverticulum perforation, active bleeding

o Relative contraindications:
* ancient cervicothoracic irradiation history (\> 10 years)
* recent upper gastrointestinal bleeding history
* presence of esophageal varices ≥ grade II
* zero cervical mobility
* Reflux Esophagitis
* Severe coagulation disorders
* Pregnancy / Breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gharib Ajob, MD

Role: PRINCIPAL_INVESTIGATOR

Strasbourg's University Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Strasbourg's New Civil Hospital, Cardiac surgical reanimation department

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6283

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.